X
Jul 01, 2021 04:49 PM (GMT+8) · EqualOcean
Guangji pharmaceutical announced that the holding subsidiary Guangji Pharmaceutical (Mengzhou) Co., Ltd. decided to suspend production of VB2 production line from July 3, taking into account the annual work plan and the need for workshop equipment maintenance and other reasons. It is estimated that the relevant expenses incurred during the shutdown period of Mengzhou company account for about 4.16% of the annual production cost, which has no significant impact on the total annual production cost.